par Renneson, J;Salio, M;Mazouz, N;Goldman, Michel
;Marchant, Arnaud
;Cerundolo, V
Référence Clinical and experimental immunology, 139, 3, page (468-475)
Publication Publié, 2005-03


Référence Clinical and experimental immunology, 139, 3, page (468-475)
Publication Publié, 2005-03
Article révisé par les pairs
Titre: |
|
Auteur: | Renneson, J; Salio, M; Mazouz, N; Goldman, Michel; Marchant, Arnaud; Cerundolo, V |
Informations sur la publication: | Clinical and experimental immunology, 139, 3, page (468-475) |
Statut de publication: | Publié, 2005-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Cancer |
Cytotoxic T cells | |
Dendritic cells | |
Vaccines | |
MeSH keywords: | CD40 Ligand -- immunology |
CD8-Positive T-Lymphocytes -- immunology | |
Cancer Vaccines | |
Cell Differentiation | |
Cell Line, Tumor | |
Dendritic Cells -- immunology | |
Flow Cytometry | |
Humans | |
Interferon-beta -- immunology | |
Interferon-gamma -- immunology | |
Interleukin-3 -- immunology | |
Interleukin-5 -- immunology | |
Lymphocyte Activation | |
Lymphoma -- immunology | |
Lymphoma -- therapy | |
T-Lymphocytes, Cytotoxic -- immunology | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0009-9104 |
info:doi/10.1111/j.1365-2249.2005.02700.x | |
info:pii/CEI2700 | |
info:scp/14744302052 | |
info:pmid/15730392 | |
PMC1809309 |